Is Take­da’s post-Shire sell-off ap­proach­ing its fi­nal days?

The Take­da sell-off may be near­ing com­ple­tion.

Mul­ti­ple Asian news out­lets re­port­ed Wednes­day that the Japan­ese drug­mak­er was near­ing a deal that would sell its over-the-counter drug busi­ness to the pri­vate eq­ui­ty firm Black­stone for over $2 bil­lion. Nikkei Asian Re­view re­port­ed the deal at 250 bil­lion yen ($2.37 bil­lion). The Japan Times quot­ed 300 bil­lion yen ($2.9 bil­lion).

Take­da did not re­spond as of pub­li­ca­tion to a re­quest for com­ment.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER